Vaccination in Mexico includes the use of vaccines in advancing public health. Mexico has a multi-year program for immunization of children. [1] The immunization of children is fully covered by the government of Mexico. [1] Mexico has an adverse events committee to monitor the adverse effects of vaccination as well as a standing technical advisory group on immunization. [1]
In Mexico, 4% of individuals received at least one dose of the COVID-19 vaccine as of March 2021. [2] Wealthy Mexicans were reported to travel to the neighboring United States for receiving their vaccinations. [2] In March, the White House announced that four million doses of COVID-19 vaccines manufactured in the United States will be sent to Mexico. [3] [4]
In a survey conducted in March 2021, 52% of Mexicans said that they were willing to get vaccinated against COVID-19, 20% said they were not sure and 28% said they would not get vaccinated. [5] As of early October, children's COVID-19 vaccination programs began, but only for those with medical conditions, yet when asked in an open survey, parents were highly interested in having their children vaccinated. Nonetheless, parents did express levels of concern involving their children developing adverse effects from the vaccine. [6]
On April 20, 2021, President López Obrador televised himself receiving the AstraZeneca vaccine. [7] [8]
The national vaccination plan against COVID-19 has been planned as below in Mexico: [9]
The following vaccines are authorized by the Mexican government for use against COVID-19 (approval date in parentheses): [9]
The recommended vaccine schedule for children in Mexico contains vaccinations against sixteen vaccine preventable diseases. [10] Vaccine doses administered in Mexico are usually valid in the United States. [11] The immunization schedule for children in Mexico is as follows:
Name | Age of administration | Diseases prevented |
---|---|---|
BCG | at birth | Tuberculosis |
Antihepatitis B | at birth, 2, 6 months | Hepatitis B |
Rotarix | 2, 4 months | Rotavirus |
Pneumococcal vaccine | 2, 4 months, 12 through 15 months | Pneumococcal pneumonia |
Antihepatitis A | 12, 18 months | Hepatitis A |
Pentavalent vaccine | 2, 4, 6, 18 months | H. influenzae type B, Pertussis, Diphtheria, Tetanus, Polio |
Varicella vaccine | 12 months | Chicken pox |
MMR vaccine | 12 months, 18 months through 6 years | Measles, Mumps, Rubella |
Influenza vaccine | 6 through 59 months, 36 months through 9 years (high risk only) | Influenza |
Human papillomavirus vaccine | 11 through 12 years (3 doses, girls only) | Human Papillomavirus |
DPT | 4 through 6 years | Diphtheria, Pertussis, Tetanus |
MR vaccine | from 10 years of age | Measles, Rubella |
Sabin vaccine | 2 doses per years, from 6 to 59 months of age in addition to prior 2 doses of IPV | Polio |
Td | from 10 years of age | Tetanus |
In addition, Vitamin A supplements are offered to all children aged 6 to 59 months. [10]
The vaccine coverage of various vaccines in Mexico are as follows, according to the most recent survey conducted by the World Health Organization in 2014:
Vaccine | Coverage |
---|---|
BCG | 93% |
DTP dose 1 | 92% |
DTP dose 3 | 72% |
Hepatitis B dose 3 | 82% |
Hib dose 3 | 72% |
Pneumococcal vaccine dose 3 | 57% |
Rotavirus vaccine | 63% |
According to the statistics from the World Health Organization (WHO), no cases of diphtheria, measles, polio or yellow fever were reported in Mexico in 2019. However, mumps and pertussis cases are on the rise in Mexico, with 8009 and 874 children reportedly having contracted mumps and pertussis respectively in 2019. There was an increase in tetanus cases from a total of 23 in 2018 to 35 in 2019. [1]
The Joint Committee on Vaccination and Immunisation (JCVI) is an independent expert advisory committee that advises United Kingdom health departments on immunisation, making recommendations concerning vaccination schedules and vaccine safety. It has a statutory role in England and Wales, and health departments in Scotland and Northern Ireland may choose to accept its advice.
The COVID-19 vaccination program in the Philippines is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. The vaccination program was initiated by the Duterte administration on March 1, 2021, a day after the arrival of the country's first vaccine doses which were donated by the Chinese government.
The COVID-19 vaccination campaign in Italy is a mass immunization campaign that was put in place by the Italian government in order to respond to the ongoing COVID-19 pandemic. It started on 27 December 2020, together with most countries in the European Union.
The general COVID-19 vaccination in Australia program began on 22 February 2021 in response to the COVID-19 pandemic, with the goal of vaccinating all willing people in Australia before 2022. Front-line workers and aged care staff and residents had priority for being inoculated, before a gradual phased release to less-vulnerable and lower-risk population groups throughout 2021. The Therapeutic Goods Administration (TGA) approved four vaccines for Australian use in 2021: the Pfizer–BioNTech vaccine on 25 January, the Oxford–AstraZeneca vaccine on 16 February, Janssen vaccine on 25 June and the Moderna vaccine on 9 August. Although approved for use, the Janssen vaccine was not included in the Australian vaccination program as of June 2021.
COVID-19 vaccination in Romania started on 27 December 2020. It was announced that the process would be divided into three phases. Medical personnel would be vaccinated first, followed by the population at risk, and finally by the rest of the population. Vaccination was declared free and non-mandatory. As of March 2022, five types of vaccines were authorized to be used in Romania. This is the largest vaccination campaign in the modern history of Romania.
COVID-19 vaccination in Canada is an ongoing, intergovernmental effort coordinated between the bodies responsible in the Government of Canada to acquire and distribute vaccines to individual provincial and territorial governments who in turn administer authorized COVID-19 vaccines during the COVID-19 pandemic in Canada. Provinces have worked with local municipal governments, hospital systems, family doctors and independently owned pharmacies to aid in part, or in full with vaccination rollout. The vaccination effort in full is the largest such immunization effort in the nation's history. The vaccination effort began December 14, 2020, and is currently ongoing.
The COVID-19 vaccination in Morocco is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
COVID-19 vaccination in Angola is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. As of 15 June 2021, Angola has administered 1,314,375 doses of vaccines.822,109 people with the first dose and 492,266 people fully vaccinated. Angola began their vaccination program shortly after receiving their first shipment of Oxford AstraZeneca vaccine in early March 2021.
COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
COVID-19 vaccination programs are ongoing in the majority countries and territories in Africa, with 51 of 54 African countries having launched vaccination programs by July 2021. As of October 2023, 51.8% of the continent's population is fully vaccinated with over 1084.5 million doses administered.
COVID-19 vaccination in Ghana began on Monday 1 March 2021 after the country became the first recipient of the Oxford-AstraZeneca COVID-19 vaccine as part of the COVAX initiative. As of 6 June 2021, Ghana has administered 1,230,000 vaccine doses.
The National Advisory Committee on Immunization is an advisory body that provides the Government of Canada with medical and scientific advice relating to human immunization.
The COVID-19 vaccination in Vietnam is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 30 January 2021, vaccinations commenced on 8 March 2021, and will continue throughout the year with the goal of vaccinating 80% of the population by June 2022. The Sputnik V was later approved for use on 23 March 2021. The Sinopharm BIBP vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were approved on 12 June 2021, 29 June 2021, and 15 July 2021, respectively. Vietnam approved Abdala vaccine from Center for Genetic Engineering and Biotechnology on 18 September 2021, and Covaxin from Bharat Biotech on 10 November 2021.
COVID-19 vaccination in Mexico is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
The COVID-19 vaccination in Indonesia is an ongoing mass immunization in response to the COVID-19 pandemic in Indonesia. On 13 January 2021, the program commenced when President Joko Widodo was vaccinated at the presidential palace. In terms of total doses given, Indonesia ranks third in Asia and fifth in the world.
COVID-19 vaccination in Nigeria is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Vaccination began on 5 March 2021. As of 28 February 2022, 17,914,944 people have received their first dose a COVID-19 vaccine, and 8,197,832 have received their second dose.
The COVID-19 vaccination campaign in Brazil is an ongoing mass immunization campaign for the COVID-19 pandemic in Brazil. It started on January 17, 2021, when the country had 210 thousand deaths.
COVID-19 vaccination in Iceland is an effort to immunize the adult population of Iceland due to the COVID-19 pandemic. As of July 2021, more than 260,000 individuals had received at least one dose of COVID-19 vaccine, which was over 78% of the country's population. On November 21, 2021, 90% of the target population had been fully vaccinated, while around 1 in 5 people had received a booster on top of that; by December 9, 2021, the share of the population having received a booster shot exceeded 50%. On December 13, 2021, the country began offering Pfizer vaccinations to children aged 5–11.
The COVID-19 vaccination campaign began in Fiji on the first quarter of 2021 and will continue throughout the year with the goal of vaccinating all eligible Fijians. The government has made it mandatory for all eligible adults to take the COVID-19 vaccines.
COVID-19 vaccination in Ontario began in December 2020, when the first doses of the Pfizer vaccine were administered. In February 2021, shipments for both the Pfizer and Moderna vaccines increased significantly. By May 2021, over 50 percent of Ontarians had received their first dose. By the beginning of 2022, over 80 percent of Ontarians had received their first dose.